HLA-DRB9 |
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
|
0.682 |
0.654 |
ZSCAN26 |
Q16670
|
zinc finger and SCAN domain containing 26
|
|
|
0.931 |
0.115 |
HCG9 |
|
HLA complex group 9
|
|
|
0.700 |
0.500 |
HCP5 |
Q6MZN7
|
HLA complex P5
|
|
|
0.595 |
0.808 |
LINC00243 |
|
long intergenic non-protein coding RNA 243
|
|
|
0.729 |
0.423 |
TRIM26BP |
|
tripartite motif containing 26B, pseudogene
|
|
|
0.861 |
0.269 |
HCG18 |
|
HLA complex group 18
|
|
|
0.722 |
0.538 |
HCG17 |
|
HLA complex group 17
|
|
|
0.769 |
0.346 |
MSH5-SAPCD1 |
|
MSH5-SAPCD1 readthrough (NMD candidate)
|
|
|
0.760 |
0.423 |
TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
EHMT2-AS1 |
|
EHMT2 and SLC44A4 antisense RNA 1
|
|
|
0.780 |
0.462 |
NOTCH4 |
Q99466
|
notch receptor 4
|
|
2.1E-23 |
0.534 |
0.731 |
SKIV2L |
Q15477
|
Ski2 like RNA helicase
|
|
1.3E-22 |
0.615 |
0.654 |
ITPR3 |
Q14573
|
inositol 1,4,5-trisphosphate receptor type 3
|
Ion channel
|
2.6E-22 |
0.555 |
0.808 |
C2 |
P06681
|
complement C2
|
|
1.3E-16 |
0.617 |
0.692 |
TSBP1 |
Q5SRN2
|
testis expressed basic protein 1
|
|
1.5E-16 |
0.638 |
0.692 |
CFB |
P00751
|
complement factor B
|
|
4.7E-16 |
0.532 |
0.769 |
SLC44A4 |
Q53GD3
|
solute carrier family 44 member 4
|
Transporter
|
1.0E-14 |
0.678 |
0.615 |
VWA7 |
Q9Y334
|
von Willebrand factor A domain containing 7
|
|
2.3E-11 |
0.839 |
0.308 |
MSH5 |
O43196
|
mutS homolog 5
|
Nucleic acid binding
|
3.2E-11 |
0.641 |
0.692 |
BTNL2 |
Q9UIR0
|
butyrophilin like 2
|
Enzyme modulator
|
8.6E-11 |
0.546 |
0.808 |
PGBD1 |
Q96JS3
|
piggyBac transposable element derived 1
|
|
4.7E-10 |
0.821 |
0.269 |
ABCF1 |
Q8NE71
|
ATP binding cassette subfamily F member 1
|
Enzyme
|
1.3E-09 |
0.674 |
0.538 |
STK19 |
P49842
|
serine/threonine kinase 19
|
|
6.7E-09 |
0.691 |
0.500 |
GPANK1 |
O95872
|
G-patch domain and ankyrin repeats 1
|
|
3.2E-07 |
0.769 |
0.385 |